Common Stock, Shares, Outstanding of NORTHWEST BIOTHERAPEUTICS INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NORTHWEST BIOTHERAPEUTICS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NORTHWEST BIOTHERAPEUTICS INC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,518,300,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NORTHWEST BIOTHERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,518,300,000 +232,000,000 +18% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,458,800,000 +229,100,000 +19% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,391,300,000 +195,900,000 +16% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 1,328,600,000 +153,100,000 +13% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,286,300,000 +141,200,000 +12% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 1,229,700,000 +114,500,000 +10% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 1,195,400,000 +112,300,000 +10% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 1,175,500,000 +107,100,000 +10% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 1,145,100,000 +1,145,098,949 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,115,200,000 +80,700,000 +7.8% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 1,083,100,000 +113,400,000 +12% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 1,068,400,000 +120,000,000 +13% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 1,051* -891,898,949 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 1,034,500,000 +177,300,000 +21% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 969,700,000 +140,100,000 +17% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 948,400,000 +118,800,000 +14% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 891,900,000 +112,200,000 +14% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 857,200,000 +135,000,000 +19% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 829,600,000 +167,500,000 +25% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 829,600,000 +215,300,000 +35% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 779,700,000 +196,900,000 +34% 30 Sep 2020 10-Q 15 Jan 2021 2020 Q3
Q2 2020 722,200,000 +159,700,000 +28% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 662,100,000 +125,000,000 +23% 31 Mar 2020 10-Q 24 Jun 2020 2020 Q1
Q4 2019 614,300,000 +91,100,000 +17% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 582,800,000 +72,700,000 +14% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 562,500,000 +117,900,000 +27% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 537,100,000 +122,400,000 +30% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 523,200,000 +194,300,000 +59% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 510,100,000 +200,425,000 +65% 30 Sep 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 444,600,000 +207,277,195 +87% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 414,700,000 +229,188,178 +124% 31 Mar 2018 10-Q 16 May 2018 2018 Q1
Q4 2017 328,900,000 +171,900,000 +109% 31 Dec 2017 10-K 02 Apr 2019 2018 FY
Q3 2017 309,675,000 +188,898,305 +156% 30 Sep 2017 10-Q 20 Nov 2017 2017 Q3
Q2 2017 237,322,805 +131,155,601 +124% 30 Jun 2017 10-Q 21 Aug 2017 2017 Q2
Q1 2017 185,511,822 +83,771,382 +82% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 157,000,000 +61,141,913 +64% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 120,776,695 +42,607,129 +55% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 106,167,204 +28,439,381 +37% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 101,740,440 +31,429,716 +45% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 95,858,087 +26,900,618 +39% 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q3 2015 78,169,566 +15,950,881 +26% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 77,727,823 +18,942,524 +32% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 70,310,724 +15,492,314 +28% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 68,957,469 +23,291,154 +51% 31 Dec 2014 10-K 16 Mar 2016 2015 FY
Q3 2014 62,218,685 +25,579,724 +70% 30 Sep 2014 10-Q 19 Nov 2014 2014 Q3
Q2 2014 58,785,299 +28,049,333 +91% 30 Jun 2014 10-Q 15 Aug 2014 2014 Q2
Q1 2014 54,818,410 +27,677,993 +102% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 45,666,315 +20,990,257 +85% 31 Dec 2013 10-K 17 Mar 2015 2014 FY
Q3 2013 36,638,961 +24,811,366 +210% 30 Sep 2013 10-Q 15 Nov 2013 2013 Q3
Q2 2013 30,735,966 -134,627,021 -81% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 27,140,417 -132,137,619 -83% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 24,676,058 +15,341,957 +164% 31 Dec 2012 10-K 01 Apr 2014 2013 FY
Q3 2012 11,827,595 -85,284,441 -88% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 165,362,987 +71,944,401 +77% 30 Jun 2012 10-Q/A 12 Sep 2012 2012 Q2
Q1 2012 159,278,036 31 Mar 2012 10-Q 21 May 2012 2012 Q1
Q4 2011 9,334,101 -63,784,370 -87% 31 Dec 2011 10-K 08 Apr 2013 2012 FY
Q3 2011 97,112,036 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 93,418,586 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 73,118,471 31 Dec 2010 10-K 13 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.